patients with an ESR of less than 15 mm/h. The mean IgA in patients having a C-reactive protein (CRP) level equal to or greater than 15 ,ug/ml (15 mg/1) was 387*8 mg/dl, 74% higher than in controls (P<0 .001), and again there was no significant difference between controls and patients with CRP levels less than 15 pg/ml. (SI conversion: g/l=mg/dl x 0.01). It is suggested that selective increase of serum IgA occurs predominantly during phases of active inflammatory disease in AS, and this finding is compatible with the concept of a microbial triggering agent acting across an IgA secreting organ such as the gut.
There is evidence that gastrointestinal infection may be an important aetiological factor in ankylosing spondylitis (AS). Sacroiliitis and AS are common sequelae in persons who develop arthritis or Reiter's disease after dysenteric infection with salmonella, shigella, or Yersinia enterocolitica.' We have reported an increased isolation of Klebsiella pneumoniae from the faeces of AS patients before and during active phases of the disease2 or during episodes of acute anterior uveitis.3 Investigation by lymphangiography has shown that pelvic and paraspinal lymphadenopathy precedes the radiological changes in AS4. Raised levels of serum IgA in patients with AS have been reported 8. Plasma cells in the gut associated lymphoid tissue are the major source of serum IgA,9 and investigations in animals raised in germ-free conditions have shown that after oral immunisation the main specific plasma cell response is IgA in character and nearly all the circulating specific antibody is IgA.10
We report here our studies on serum immunoglobulin levels in AS.
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Patients and methods
Blood was obtained from 122 AS patients during varying phases of disease activity. A total of 221 patient sera were randomly selected from a bank of stored sera, each patient being selected on average twice (range 1-5). Each patient visit was considered as 1 separate event, the shortest interval between visits being 1 month. The New York criteria were used for the diagnosis of AS.'1 Patients with inflammatory bowel disease were excluded from the study. The mean age of all patients was 34@5 years (range 11-68), and 29 were women. Of 117 patients tested 110 were HLA B27 positive (94%). Single serum samples were obtained from 58 healthy subjects corresponding in age and sex distribution to the AS patients and who had no history of arthritis or backache.
Serum Ankylosing Spondylitis Patients
IgM
The mean serum IgM in AS patients was 149 mg/dl, which is a 6 % rise compared to the mean serum IgM obtained for control subjects, but this difference is not statistically significant (Fig. IC) . Furthermore, when patients were divided into groups with increased inflammatory activity, again there was no statistically significant difference between serum IgM levels in patients with elevated ESR or CRP and control subjects (Fig. IC) occur along the axial skeleton and in peripheral joint and eye tissues, but this is unlikely to explain the marked elevation in serum IgA, a class of immunoglobulin produced mainly within the mucosal associated lymphoid tissues of the gastrointestinal tract.9
This finding strongly suggests that some external triggering factor is acting across a mucosal surface such as the lower gastrointestinal tract, initiating the rise in IgA and possibly the associated inflammatory disease. We have previously demonstrated an increased isolation of Klebsiella pneumoniae from the faeces of AS patients with active joint and eye disease2 3 and have also found that elevated ESR and CRP both independently correlated with positive faecal cultures for this micro-organism.'2
Lymphangiographic studies indicate that regional lymph nodes draining the pelvis, pelvic colon, and rectum, the presacral and para-aortic lymph nodes, become enlarged during the active or progressive phase of AS and before the development of radiographic changes. 
